STAT - Reporting from the frontiers of health and medicine

Skip to Main Content

Explore what it takes to make the health care system work.

Explore what it takes to make the health care system work.

April 30, 2024

In a big reversal, Walmart to shut down medical clinics and online care
April 30, 2024

‘Skinny labels’ on generic medicines saved Medicare $15 billion over a recent six-year period
April 30, 2024

FTC issues warnings on ‘junk’ patent listings for Ozempic and other drugs
April 30, 2024

Akili to lay off 46% of its staff, explore strategic options amid sluggish sales
April 30, 2024

Former MIT biologist David Sabatini, forced out after sexual harassment accusations, to lead new Boston team
April 30, 2024

FDA wants to hear your thoughts on advisory committees

The Obesity Revolution

What we’re starting to learn about H5N1 in cows, and the risk to people

At this point in the H5N1-in-cows story, there are questions without solid answers, though some evidence is coming into focus.

Health April 30, 2024

With younger women getting breast cancer, national panel lowers mammogram screening age to 40

Politics April 30, 2024

DEA will move to reclassify marijuana in a historic shift, AP sources say

First Opinion April 30, 2024

Creating the next wave of antibody therapies requires innovative collaboration

Politics April 29, 2024

STAT Plus: Biden cybersecurity plan for hospitals entails carrots first, then sticks, health official says

Sponsored

Advertisement

All First Opinion

STAT+

Your go-to source for the world of life sciences, medicine, and biopharma. Subscribe now.

Cancel anytime.

New, serious safety risk related to MorphoSys’ cancer drug complicates, potentially threatens, Novartis acquisition

‘Devalued, disempowered, and unseen’: Mass General Brigham doctors react to latest merger step

Federal judge rules against two drugmakers challenging Medicare drug price negotiation program

Ono Pharmaceutical to acquire Deciphera Pharma, maker of cancer drugs, for $2.4 billion

All STAT+ Stories

All Events

More From STAT

More From STAT

More From STAT

STAT offers a variety of in-person and virtual events throughout the year.

All Events

2024 STAT Breakthrough Summit West

San Francisco, CA May 16, 2024

A one-day event focused on 'Medicine’s future, now' — where we'll explore opportunities and the latest advancements in medical science and technology.

31

May

STAT@ASCO: Pathways to Progress

Chicago, IL

08

May

Navigating a New Era in Alzheimer’s Treatment

Virtual

21

May

Closing the Information Gap: Chronic Disease, Pregnancy, and Breastfeeding

Virtual

All Events

More Stories

Business April 30, 2024

STAT Plus: In a big reversal, Walmart to shut down medical clinics and online care

Pharmalot April 30, 2024

STAT Plus: ‘Skinny labels’ on generic medicines saved Medicare $15 billion over a recent six-year period

Pharmalot April 30, 2024

STAT Plus: FTC issues warnings on ‘junk’ patent listings for Ozempic and other drugs

Health tech April 30, 2024

STAT Plus: Akili to lay off 46% of its staff, explore strategic options amid sluggish sales

In the Lab April 30, 2024

STAT Plus: Former MIT biologist David Sabatini, forced out after sexual harassment accusations, to lead new Boston team

The Readout April 30, 2024

FDA wants to hear your thoughts on advisory committees

Biotech April 30, 2024

STAT Plus: Eli Lilly raises earnings guidance as it ramps up Mounjaro, Zepbound manufacturing

Politics April 30, 2024

Backers of menthol cigarette ban vow to keep up the fight, but concede it will be a long battle

First Opinion April 30, 2024

Protect the health of pregnant people and their children by including them in research

First Opinion April 30, 2024

The medical loss ratio has become a barrier to preventive care

Politics April 29, 2024

Expanded methadone access: giving patients greater choice

Politics April 29, 2024

STAT Plus: Federal judge rules against two drugmakers challenging Medicare drug price negotiation program

Pharmalot April 30, 2024

STAT Plus: Pharmalittle: We’re reading about a Medicare price-negotiation ruling, pharma’s slipping reputation, and more

Politics April 29, 2024

STAT Plus: FDA finalizes plan to regulate some lab-developed tests

Biotech April 29, 2024

STAT Plus: Activist investor Alex Denner, Bioverativ shareholder reach tentative settlement in insider trading case

Health Care Inc. April 29, 2024

STAT Plus: Biden administration boosts some Medicaid payments to match commercial rates

The Readout April 29, 2024

STAT Plus: House bill aimed at Chinese biotechs is advancing

Pharmalot April 29, 2024

STAT Plus: Pharmalittle: We’re reading about MorphoSys drug risks, an AstraZeneca admission, and more

First Opinion April 29, 2024

Medical students lose in the research arms race for residency slots

First Opinion April 29, 2024

Unseen battles: The harsh realities of veterans’ access to health care

First Opinion April 28, 2024

Déjà WTO: The WHO’s pandemic agreement shouldn’t water down intellectual property obligations

Letters to the editor April 27, 2024

STAT readers respond to First Opinion essays on site-neutral payments, free medical school tuition, and more

First Opinion April 26, 2024

True peer-to-peer conversations will improve prior authorization

First Opinion April 26, 2024

Solving academic medical centers’ existential crisis

Newsletters

Mon - Fri

Your daily dose of news in health and science

Elizabeth Cooney

Our Picks

Our Picks

STAT’s selection of must-read stories and investigations

Your dog is probably on Prozac. Experts say that says more about the American mental health crisis than pets

By Sarah Owermohle

STAT Plus: When a cancer drug fails, oncologists often fly blind. A precision technique might light the way

STAT Plus: HCA reports almost $1 billion more in charity care to Medicare than to its shareholders, drawing more taxpayer money

STAT Plus: DNA test that predicts opioid addiction should be pulled off the market, critics urge the FDA

By Megan Molteni

What we know about H5N1 bird flu in cows — and the risk to humans

By Helen Branswell

STAT Plus: Did you say 486%? Why one company thinks such a price hike for its drug is justified

By Ed Silverman

STAT Plus: This AI company scans penis pictures for STIs. Its unproven tech is in an FDA gray zone

By Lizzy Lawrence

STAT Plus: The methadone clinic monopoly: Opioid treatment chains backed by private equity are fighting calls for reform

STAT Plus: Biogen’s Alzheimer’s drug launch on ‘steady pace’ as logistical hurdles recede

Biotech April 24, 2024

STAT Plus: Biogen’s Alzheimer’s drug launch on ‘steady pace’ as logistical hurdles recede

Biotech April 24, 2024

STAT Plus: New studies suggest GLP-1 health care costs have only begun to climb

Biotech April 24, 2024

STAT Plus: Novo Nordisk’s move to discontinue an insulin leaves patients to ‘pick up the pieces’

STAT Plus: Doctors Without Borders challenges pharma by releasing costs for a key clinical trial

Pharmalot April 29, 2024

STAT Plus: Doctors Without Borders challenges pharma by releasing costs for a key clinical trial

Pharmalot April 26, 2024

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot April 26, 2024

STAT Plus: Pharmalittle: We’re reading about Cigna biosimilar plans, a Vertex deal in South Africa, and more

Cattle testing for H5N1 bird flu will be more limited than USDA initially announced

Health April 26, 2024

Cattle testing for H5N1 bird flu will be more limited than USDA initially announced

Health April 25, 2024

STAT Plus: Why a British hospital, and not a drugmaker, is trying to get a rare disease therapy approved

Health April 24, 2024

Equity, technology, and costs top of mind for life science’s leaders

STAT Plus: Biden administration punts menthol cigarette rule indefinitely

Politics April 26, 2024

STAT Plus: Biden administration punts menthol cigarette rule indefinitely

Politics April 26, 2024

STAT Plus: Momentum builds for House bill cracking down on Chinese biotechs

Politics April 24, 2024

STAT Plus: Supreme Court judges wrestle with abortion access in emergency cases

Video

What we know about traces of H5N1 bird flu found in pasteurized milk

STAT Plus: Medicare billing forms are running out of space for growing health care prices

Watch: Why fentanyl withdrawal is agony and how medication can prevent it

What is in utero gene editing?

War on Recovery

War on Recovery

Philips will pay $1.1 billion to resolve U.S. lawsuits over breathing machines that expel debris

Health tech April 29, 2024

Philips will pay $1.1 billion to resolve U.S. lawsuits over breathing machines that expel debris

Health tech April 29, 2024

STAT Plus: AI is becoming the exclusive province of academic medicine. A new initiative aims to change that

Health tech April 25, 2024

STAT Plus: Generative AI is supposed to save doctors from burnout. New data show it needs more training

STAT Plus: After AI protein folding, David Baker’s lab identifies millions of smaller drug candidates

In the Lab April 25, 2024

STAT Plus: After AI protein folding, David Baker’s lab identifies millions of smaller drug candidates

In the Lab April 23, 2024

STAT Plus: NIH postdocs will get a raise next year — but not as much as they hoped

In the Lab April 22, 2024

STAT Plus: In a scientific first, researchers use CRISPR base editing to treat liver disease in fetal monkeys

STAT Plus: Another hospital sues MultiPlan, alleging scheme to ‘suppress’ payments

Hospitals April 26, 2024

STAT Plus: Another hospital sues MultiPlan, alleging scheme to ‘suppress’ payments

Hospitals April 24, 2024

STAT Plus: FTC’s noncompete ban immediately challenged in Texas district lawsuit

Hospitals April 24, 2024

STAT Plus: Anticompetitive hospital mergers skate by due to FTC’s shallow resources

STAT Plus: Elevance’s private equity deal will form $4 billion primary care company

Insurance April 18, 2024

STAT Plus: Elevance’s private equity deal will form $4 billion primary care company

Insurance April 16, 2024

STAT Plus: UnitedHealth reaffirms financial outlook despite up to $1.6 billion hit from Change Healthcare cyberattack

Insurance April 9, 2024

STAT Plus: MassMutual is rolling out free genetic testing for members, a dicey area for life insurers

Podcasts

Vertex’s big deal, biotech’s red numbers, & an industry history lesson

Biotech mega-rounds, a cancer vaccine setback & CEOs keep their promise

What the mifepristone case means, GLP-1 skepticism, & Chinese biotech

Live! From the STAT Breakthrough Summit East